Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001031156 | SCV001194462 | pathogenic | Mucopolysaccharidosis, MPS-II | 2019-08-22 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts exons 5-6 in IDS. Other in-frame deletions that disrupt this region have been observed in individuals with IDS-related conditions (PMID: 30639582, 24125893, 9921913), which suggests that this may be a clinically significant region of the protein This variant has been observed in an individual affected with mucopolysaccharidosis type II (PMID: 9921913). This variant is an in-frame deletion of the genomic region encompassing exons 5-6 of the IDS gene. It preserves the integrity of the reading frame. |